Endovascular Treatment and Outcomes for Femoropopliteal In-Stent Restenosis: Insights from the XLPAD Registry

Figure 2

Survival curves comparing patients with femoropopliteal (FP) opliteal in-stent restenosis (ISR) and without ISR receiving endovascular treatment for symptomatic peripheral arterial disease (PAD). Kaplan–Meier curves showing that patients with FP ISR did not have significantly lower freedom from MALE at 12 months (a). Survival from target limb revascularization was significantly lower in the FP ISR group (b).

(a)

(b)